These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35301247)

  • 1. The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
    Badagliacca R; Papa S; D'Alto M; Ghio S; Agostoni P; Ameri P; Argiento P; Brunetti ND; Casamassima V; Casu G; Cedrone N; Confalonieri M; Corda M; Correale M; D'Agostino C; De Michele L; Famoso G; Galgano G; Greco A; Lombardi CM; Manzi G; Madonna R; Mercurio V; Mulè M; Paciocco G; Romaniello A; Romeo E; Scelsi L; Serra W; Stolfo D; Toma M; Vatrano M; Vitulo P; Vizza CD;
    Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35301247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension.
    Manzi G; Papa S; Mariani MV; Scoccia G; Filomena D; Malerba C; Adamo FI; Caputo A; De Lazzari C; De Lazzari B; Cedrone N; Madonna R; Recchioni T; Serino G; Vizza CD; Badagliacca R
    Vascul Pharmacol; 2022 Aug; 145():107024. PubMed ID: 35716991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
    Wesley Milks M; Sahay S; Benza RL; Farber HW
    J Heart Lung Transplant; 2021 Mar; 40(3):172-182. PubMed ID: 33414063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation.
    Wang D; Gomes MT; Mo Y; Prohaska CC; Zhang L; Chelvanambi S; Clauss MA; Zhang D; Machado RF; Gao M; Bai Y
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
    Hoeper MM; Al-Hiti H; Benza RL; Chang SA; Corris PA; Gibbs JSR; Grünig E; Jansa P; Klinger JR; Langleben D; McLaughlin VV; Meyer GMB; Ota-Arakaki J; Peacock AJ; Pulido T; Rosenkranz S; Vizza CD; Vonk-Noordegraaf A; White RJ; Chang M; Kleinjung F; Meier C; Paraschin K; Ghofrani HA; Simonneau G;
    Lancet Respir Med; 2021 Jun; 9(6):573-584. PubMed ID: 33773120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
    Serati A; Keshmiri MS; Shafaghi S; Mohammad MM; Kashani BS; Naghashzadeh F; Mohamadifar A; Shafaghi M; Noorali S; Hajimoradi M; Astani B; Aghdasi S; Riahi M; Alavi S; Malek R; Movahed MR
    Crit Pathw Cardiol; 2023 Jun; 22(2):60-64. PubMed ID: 37220659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
    Charif F; Dakroub F; Bou Akl I; Kularatne M; Montani D
    Respir Med Res; 2023 Nov; 84():101053. PubMed ID: 38236767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
    Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
    Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 patients may become predisposed to pulmonary arterial hypertension.
    Suzuki YJ; Nikolaienko SI; Shults NV; Gychka SG
    Med Hypotheses; 2021 Feb; 147():110483. PubMed ID: 33444904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
    Takatsuki S; Wagner BD; Ivy DD
    Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of pulmonary arterial hypertension on SARS-CoV-2 outcomes: U.S. pre-vaccination analysis.
    Tamimi O; Ejikeme C; Nisar T; Gotur D; Safdar Z
    Curr Probl Cardiol; 2024 Aug; 49(8):102672. PubMed ID: 38795805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
    Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Rosenkranz S; Lange TJ
    J Heart Lung Transplant; 2022 Jul; 41(7):971-981. PubMed ID: 35430147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Reminder of Skin Cancer During the COVID-19 Pandemic.
    Šitum M; Filipović N; Buljan M
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Risk Assessment Tools and Prognostic Scores in Managing Patients with Pulmonary Arterial Hypertension.
    Kanwar M; Raina A; Lohmueller L; Kraisangka J; Benza R
    Curr Hypertens Rep; 2019 Apr; 21(6):45. PubMed ID: 31025123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
    Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P; Shen E; Manaker S
    Lung; 2020 Feb; 198(1):65-86. PubMed ID: 31722043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 Pandemic on Pulmonary Hypertension Patients: Insights from the BNP-PL National Database.
    Mamzer A; Waligora M; Kopec G; Ptaszynska-Kopczynska K; Kurzyna M; Darocha S; Florczyk M; Mroczek E; Mularek-Kubzdela T; Smukowska-Gorynia A; Wrotynski M; Chrzanowski L; Dzikowska-Diduch O; Perzanowska-Brzeszkiewicz K; Pruszczyk P; Skoczylas I; Lewicka E; Blaszczak P; Karasek D; Kusmierczyk-Droszcz B; Mizia-Stec K; Kaminski K; Jachec W; Peregud-Pogorzelska M; Doboszynska A; Gasior Z; Tomaszewski M; Pawlak A; Zablocka W; Ryczek R; Widejko-Pietkiewicz K; Kasprzak JD
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.